Anti-tumor activity, safety and pharmacokinetics (PK) of AGS15E (ASG-15ME) in a phase I dose escalation trial in patients (Pts) with metastatic urothelial cancer (mUC). Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Petrylak, Daniel Peter
  • Heath, Elisabeth I
  • Sonpavde, Guru
  • George, Saby
  • Morgans, Alicia Katherine
  • Eigl, Bernhard J
  • Picus, Joel
  • Cheng, Susanna Y
  • Hotte, Sebastien
  • Gartner, Elaina M
  • Vincent, Martha
  • Chu, Rong
  • Anand, Banmeet
  • Morrison, Karen
  • Jackson, Lynnae
  • Reyno, Leonard M
  • Yu, Evan Y

publication date

  • May 20, 2016